AAAAAA
Results: 1-25/35
Authors:
ALBERTIONI F
LINDEMALM S
REICHELOVA V
PETTERSSON B
ERIKSSON S
JULIUSSON G
LILIEMARK J
Citation: F. Albertioni et al., PHARMACOKINETICS OF CLADRIBINE IN PLASMA AND ITS 5'-MONOPHOSPHATE AND5'-TRIPHOSPHATE IN LEUKEMIC-CELLS OF PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, Clinical cancer research, 4(3), 1998, pp. 653-658
Authors:
ALBERTIONI F
LINDEMALM S
REICHELOVA V
PETTERSSON B
ERIKSSON S
JULIUSSON G
LILIEMARK J
Citation: F. Albertioni et al., PHARMACOKINETICS OF CLADRIBINE IN PLASMA AND ITS 5'-MONOPHOSPHATE AND5'-TRIPHOSPHATE IN LEUKEMIC-CELLS OF PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA, Clinical cancer research, 4(3), 1998, pp. 653-658
Authors:
ALBERTIONI F
LOTFI K
WANG Y
XU D
KNAUST E
LILLEMARK E
ERIKSSON S
Citation: F. Albertioni et al., CROSS-RESISTANCE TO CLADRIBINE (CDA) AND CYTARABINE (ARA-C) IN HUMAN ETOPOSIDE-RESISTANT CELL-LINES, Annals of oncology, 9, 1998, pp. 562-562
Authors:
LEEGWATER PAJ
DEABREU RA
ALBERTIONI F
Citation: Paj. Leegwater et al., ANALYSIS OF DNA METHYLATION OF THE 5' REGION OF THE DEOXYCYTIDINE KINASE GENE IN CCRF-CEM-SENSITIVE AND CLADRIBINE (CDA)-RESISTANT AND 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSIN (CAFDA)-RESISTANT CELLS, Cancer letters, 130(1-2), 1998, pp. 169-173
Authors:
RASK C
ALBERTIONI F
BENTZEN SM
SCHROEDER H
PETERSON C
Citation: C. Rask et al., CLINICAL AND PHARMACOKINETIC RISK-FACTORS FOR HIGH-DOSE METHOTREXATE-INDUCED TOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - A LOGISTIC-REGRESSION ANALYSIS, Acta oncologica, 37(3), 1998, pp. 277-284
Authors:
LINDEMALM S
ALBERTIONI F
LILIEMARK J
Citation: S. Lindemalm et al., STABILITY AND ANALYSIS OF 2-CHLORO-2'-DEOXYADENOSINE, 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE AND 2-CHLOROADENINE IN HUMAN BLOOD-PLASMA, Anti-cancer drugs, 8(5), 1997, pp. 445-453
Authors:
ALBERTIONI F
RASK C
SCHROEDER H
PETERSON C
Citation: F. Albertioni et al., MONITORING OF METHOTREXATE AND 7-HYDROXYMETHOTREXATE IN SALIVA FROM CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA RECEIVING HIGH-DOSE CONSOLIDATION TREATMENT - RELATION TO ORAL MUCOSITIS, Anti-cancer drugs, 8(2), 1997, pp. 119-124
Authors:
SPASOKOUKOTSKAJA T
SASVARISZEKELY M
ALBERTIONI F
ERIKSSON S
STAUB M
Citation: T. Spasokoukotskaja et al., EFFECT OF DEOXYNUCLEOSIDE ANALOGS ON THE ACTIVITY OF DEOXYCYTIDINE KINASE, The FASEB journal, 11(9), 1997, pp. 1507-1507
Authors:
REICHELOVA V
ALBERTIONI F
LILIEMARK J
Citation: V. Reichelova et al., DETERMINATION OF 2-CHLORO-2'-DEOXYADENOSINE NUCLEOTIDES IN LEUKEMIC-CELLS BY ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 682(1), 1996, pp. 115-123
Authors:
ODARCEDERLOF I
ERIKSSON CG
ALBERTIONI F
ERICSSON F
KJELLSTRAND CM
Citation: I. Odarcederlof et al., ASSESSMENT OF TOTAL-BODY WATER IN HEMODIALYSIS-PATIENTS BY A SINGLE ORAL DOSE OF ANTIPYRINE, ASAIO journal, 42(4), 1996, pp. 271-274
Authors:
RASK C
ALBERTIONI F
SCHRODER H
PETERSON C
Citation: C. Rask et al., ORAL MUCOSITIS IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER HIGH-DOSE METHOTREXATE TREATMENT WITHOUT DELAYED ELIMINATION OF METHOTREXATE - RELATION TO PHARMACOKINETIC PARAMETERS OF METHOTREXATE, Pediatric hematology and oncology, 13(4), 1996, pp. 359-367
Authors:
LILIEMARK J
ALBERTIONI F
JULIUSSON G
EKSBORG S
Citation: J. Liliemark et al., A LIMITED SAMPLING STRATEGY FOR ESTIMATION OF THE CLADRIBINE PLASMA AREA UNDER THE CONCENTRATION VERSUS TIME CURVE AFTER INTERMITTENT IV INFUSION, SC INJECTION, AND ORAL-ADMINISTRATION, Cancer chemotherapy and pharmacology, 38(6), 1996, pp. 536-540
Authors:
EKSBORG S
ALBERTIONI F
RASK C
BECK O
PALM C
SCHROEDER H
PETERSON C
Citation: S. Eksborg et al., METHOTREXATE PLASMA PHARMACOKINETICS - IMPORTANCE OF ASSAY-METHOD, Cancer letters, 108(2), 1996, pp. 163-169
Authors:
LAFOLIE P
BECK O
LIN Z
ALBERTIONI F
BOREUS L
Citation: P. Lafolie et al., URINE AND PLASMA PHARMACOKINETICS OF CODEINE IN HEALTHY-VOLUNTEERS - IMPLICATIONS FOR DRUGS-OF-ABUSE TESTING, Journal of analytical toxicology, 20(7), 1996, pp. 541-546
Authors:
HEDMAN J
SEIDEMAN P
ALBERTIONI F
STENIUSAARNIALA B
Citation: J. Hedman et al., CONTROLLED TRIAL OF METHOTREXATE IN PATIENTS WITH SEVERE CHRONIC ASTHMA, European Journal of Clinical Pharmacology, 49(5), 1996, pp. 347-349
Authors:
ALBERTIONI F
RASK C
EKSBORG S
POULSEN JH
PETTERSON B
BECK O
SCHROEDER H
PETERSON C
Citation: F. Albertioni et al., EVALUATION OF CLINICAL ASSAYS FOR MEASURING HIGH-DOSE METHOTREXATE INPLASMA, Clinical chemistry, 42(1), 1996, pp. 39-44
Authors:
ALBERTIONI F
PETTERSSON B
BECK O
RASK C
SEIDEMAN P
PETERSON C
Citation: F. Albertioni et al., SIMULTANEOUS QUANTITATION OF METHOTREXATE AND ITS 2 MAIN METABOLITES IN BIOLOGICAL-FLUIDS BY A NOVEL SOLID-PHASE EXTRACTION PROCEDURE USINGHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 665(1), 1995, pp. 163-170
Authors:
ALBERTIONI F
GRUBER A
ARESTROM I
VITOLS S
Citation: F. Albertioni et al., MULTIDRUG-RESISTANCE GENE (MDR1) RNA LEVELS IN RELATION TO P-GLYCOPROTEIN CONTENT OF LEUKEMIC-CELLS FROM PATIENTS WITH ACUTE-LEUKEMIA, Medical oncology, 12(2), 1995, pp. 79-86
Authors:
GRUBER A
ARESTROM I
ALBERTIONI F
BJORKHOLM M
PETERSON C
Citation: A. Gruber et al., MULTIDRUG-RESISTANCE (MDR1) GENE-EXPRESSION IN PERIPHERAL BLASTS FROMPATIENTS WITH ACUTE-LEUKEMIA ONLY RARELY INCREASES DURING DISEASE PROGRESSION AFTER COMBINATION CHEMOTHERAPY, Leukemia & lymphoma, 18(5-6), 1995, pp. 435-442
Authors:
JULIUSSON G
HELDAL D
HIPPE E
HEDENUS M
MALM C
WALLMAN K
STOLT CM
EVENSEN SA
ALBERTIONI F
TJONNFJORD G
LENKEI R
LILIEMARK J
Citation: G. Juliusson et al., SUBCUTANEOUS INJECTIONS OF 2-CHLORODEOXYADENOSINE FOR SYMPTOMATIC HAIRY-CELL LEUKEMIA, Journal of clinical oncology, 13(4), 1995, pp. 989-995
Authors:
LILIEMARK J
ALBERTIONI F
EDLUND C
JULIUSSON G
Citation: J. Liliemark et al., BIOAVAILABILITY AND BACTERIAL-DEGRADATION OF RECTALLY ADMINISTERED 2-CHLORO-2'-DEOXYADENOSINE, Journal of pharmaceutical and biomedical analysis, 13(4-5), 1995, pp. 661-665
Authors:
REICHELOVA V
LILIEMARK J
ALBERTIONI F
Citation: V. Reichelova et al., LIQUID-CHROMATOGRAPHIC STUDY OF ACID STABILITY OF 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE, 2-CHLORO-2'-DEOXYADENOSINE AND RELATED ANALOGS, Journal of pharmaceutical and biomedical analysis, 13(4-5), 1995, pp. 711-714
Authors:
ALBERTIONI F
HASSAN M
SILBERRING J
LILIEMARK J
Citation: F. Albertioni et al., KINETICS AND METABOLISM OF 2-CHLORO-2'-DEOXYADENOSINE AND 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE IN THE ISOLATED-PERFUSED RAT-LIVER, European journal of drug metabolism and pharmacokinetics, 20(3), 1995, pp. 225-232
Authors:
REICHELOVA V
LILIEMARK J
ALBERTIONI F
Citation: V. Reichelova et al., STRUCTURE-ACTIVITY-RELATIONSHIPS OF 2-CHLORO-2'-ARABINO-FLUORO-2'-DEOXYADENOSINE AND RELATED ANALOGS - PROTEIN-BINDING, LIPOPHILICITY, AND RETENTION IN REVERSED-PHASE LC, Journal of liquid chromatography, 18(6), 1995, pp. 1123-1135
Authors:
ALBERTIONI F
PETTERSSON B
OHLMAN S
PETERSON C
Citation: F. Albertioni et al., ANALYSIS OF AZATHIOPRINE AND 6-MERCAPTOPURINE IN PLASMA IN RENAL-TRANSPLANT RECIPIENTS AFTER ADMINISTRATION WITH ORAL AZATHIOPRINE, Journal of liquid chromatography, 18(20), 1995, pp. 3991-4005